3,367
Views
47
CrossRef citations to date
0
Altmetric
Research Paper - Translational

Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy

, , , , , , , , , & show all
Pages 1831-1844 | Received 23 Aug 2017, Accepted 11 Jun 2018, Published online: 17 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Wanyi Ng, Chenyuan Gong, Xuewei Yan, Guifan Si, Chen Fang, Lixin Wang, Xiaowen Zhu, Zihang Xu, Chao Yao & Shiguo Zhu. (2021) Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cells. Pharmaceutical Biology 59:1, pages 47-53.
Read now
Chenyu Yang, Yixiu Wang, Weijie Xue, Yuwei Xie, Qian Dong & Chengzhan Zhu. (2020) Competing Endogenous RNA (ceRNA) Network Analysis of Autophagy-Related Genes in Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine 13, pages 445-462.
Read now
Zihang Xu, Xiaowen Zhu, Lin Su, Chunpu Zou, Xiao Chen, Yifei Hou, Chenyuan Gong, Wanyi Ng, Zhongya Ni, Lixin Wang, Xuewei Yan, Yangzhuangzhuang Zhu, Xiaoning Jiao, Chao Yao & Shiguo Zhu. (2020) A high-throughput assay for screening natural products that boost NK cell-mediated killing of cancer cells. Pharmaceutical Biology 58:1, pages 357-366.
Read now

Articles from other publishers (44)

Manuela Giansanti, Tobias Theinert, Sarah Katharina Boeing, Dorothee Haas, Paul-Gerhardt Schlegel, Paola Vacca, Francesca Nazio & Ignazio Caruana. (2023) Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies. Molecular Cancer 22:1.
Crossref
Weiyi Pan, Tao Tao, Yishu Qiu, Xiao Zhu & Xiaorong Zhou. (2023) Natural Killer Cells at the Forefront of Cancer Immunotherapy with Immune Potency, Genetic Engineering, and Nanotechnology. Critical Reviews in Oncology/Hematology, pages 104231.
Crossref
Shutong Li, Aoxue Wang, Yongya Wu, Shengyuan He, Wen Shuai, Min Zhao, Yumeng Zhu, Xiuying Hu, Yubin Luo & Guan Wang. (2023) Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy. Immunological Reviews.
Crossref
Prashant Kesharwani, Ruiyang Ma, Liang Sang, Mahak Fatima, Afsana Sheikh, Mohammed A. S. Abourehab, Neelima Gupta, Zhe-Sheng Chen & Yun Zhou. (2023) Gold nanoparticles and gold nanorods in the landscape of cancer therapy. Molecular Cancer 22:1.
Crossref
Wenyan Zhang, Chen Li, Yujun Zhang, Yuanan Lu & Xueqin Liu. (2023) Study on the inhibitory effect of rocaglamide against Micropterus salmoides rhabdovirus (MSRV). Aquaculture, pages 739710.
Crossref
Fajin Li, Jianhuo Fang, Yifan Yu, Sijia Hao, Qin Zou, Qinglin Zeng & Xuerui Yang. (2023) Reanalysis of ribosome profiling datasets reveals a function of rocaglamide A in perturbing the dynamics of translation elongation via eIF4A. Nature Communications 14:1.
Crossref
Mehrafza Topa Esfandiyari, Maryam Balibegloo & Nima Rezaei. 2023.
Le Tong, Carlos Jiménez-Cortegana, Apple H.M. Tay, Stina Wickström, Lorenzo Galluzzi & Andreas Lundqvist. (2022) NK cells and solid tumors: therapeutic potential and persisting obstacles. Molecular Cancer 21:1.
Crossref
Priyanka Mudaliar, Apoorva Nalawade, Shine Devarajan & Jyotirmoi Aich. (2022) Therapeutic potential of autophagy activators and inhibitors in lung and breast cancer- a review. Molecular Biology Reports 49:11, pages 10783-10795.
Crossref
Xiaorui Liu, Jingjing Li, Qingxiang Wang, Lu Bai, Jiyuan Xing, Xiaobo Hu, Shuang Li & Qinggang Li. (2022) Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq. Frontiers in Immunology 13.
Crossref
Ling Zou, Minru Liao, Yongqi Zhen, Shiou Zhu, Xiya Chen, Jin Zhang, Yue Hao & Bo Liu. (2022) Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications. Acta Pharmaceutica Sinica B 12:10, pages 3743-3782.
Crossref
Fu Peng, Minru Liao, Rui Qin, Shiou Zhu, Cheng Peng, Leilei Fu, Yi Chen & Bo Han. (2022) Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduction and Targeted Therapy 7:1.
Crossref
Guang he Ran, Yu qing Lin, Lei Tian, Tao Zhang, Dong mei Yan, Jian hua Yu & You cai Deng. (2022) Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Signal Transduction and Targeted Therapy 7:1.
Crossref
Xing Zhang, Qiujun Guo, Conghuang Li, Rui Liu, Tao Xu, Zhichao Jin, Yupeng Xi, Yinggang Qin, Weidong Li, Shuntai Chen, Ling Xu, Lizhu Lin, Kang Shao, Shenyu Wang, Ying Xie, Hong Sun, Ping Li, Xiangyang Chu, Kequn Chai, Qijin Shu, Yanqing Liu, Yue Zhang, Jiaqi Hu, Bolun Shi, Xiwen Zhang, Zhenhua Zhang, Juling Jiang, Shulin He, Jie He, Mingxi Sun, Ying Zhang, Meiying Zhang, Honggang Zheng, Wei Hou & Baojin Hua. (2022) Immortal Time Bias-Corrected Effectiveness of Traditional Chinese Medicine in Non-Small Cell Lung Cancer (C-EVID): A Prospective Cohort Study. Frontiers in Oncology 12.
Crossref
Éilis Russell, Melissa J. Conroy & Martin P. Barr. (2022) Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer. Cells 11:4, pages 605.
Crossref
Shichun Li, Baokai Dou, Shi Shu, Luyao Wei, Shiguo Zhu, Zunji Ke & Zhifei Wang. (2022) Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3. Frontiers in Pharmacology 12.
Crossref
Yuchong Zhao, Yun Wang, Wei Chen, Shuya Bai, Wang Peng, Mengli Zheng, Yilei Yang, Bin Cheng & Zhou Luan. (2021) Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. Cancer Cell International 21:1.
Crossref
Ming Zhuang, Shan Jiang, Anxin Gu, Xuesong Chen & Mingyan E. (2021) Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer. Translational Oncology 14:12, pages 101210.
Crossref
Le Kang, Ming-san Miao, Ya-gang Song, Xiao-yan Fang, Jin Zhang, Ya-nan Zhang & Jin-xin Miao. (2021) Total flavonoids of Taraxacum mongolicum inhibit non-small cell lung cancer by regulating immune function. Journal of Ethnopharmacology 281, pages 114514.
Crossref
Meng-Yu Zhang, Chen Huo, Jian-Yu Liu, Zhuang-E. Shi, Wen-Di Zhang, Jia-Jia Qu, Yue-Liang Yue & Yi-Qing Qu. (2021) Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Yi Yang, Qinying Liu, Xianai Shi, Qiuhong Zheng, Li Chen & Yang Sun. (2021) Advances in plant-derived natural products for antitumor immunotherapy. Archives of Pharmacal Research 44:11, pages 987-1011.
Crossref
Sonia Núñez-Vázquez, José Saura-Esteller, Ismael Sánchez-Vera, Emma Guilbaud, Ana M. Cosialls, Gabriel Pons, Jean-Ehrland Ricci, Daniel Iglesias-Serret, Sandrine Marchetti & Joan Gil. (2021) The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells. Oncogenesis 10:9.
Crossref
Yongqin Zeng, Xiuzhi Lv & Juan Du. (2021) Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review). Oncology Reports 46:5.
Crossref
Zhan Zheng, Yue Ma, Lifang Wang, Haibin Deng, Zhongqi Wang, Jianwen Li & Zhenye Xu. (2021) Chinese herbal medicine Feiyanning cooperates with cisplatin to enhance cytotoxicity to non-small-cell lung cancer by inhibiting protective autophagy. Journal of Ethnopharmacology 276, pages 114196.
Crossref
Yufang Sun, Chenyuan Gong, Zhongya Ni, Dan Hu, Wanyi Ng, Xiaowen Zhu, Lixin Wang, Guifan Si, Xuewei Yan, Chen Zhao, Chao Yao & Shiguo Zhu. (2021) Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5. Journal of Leukocyte Biology 110:2, pages 315-325.
Crossref
Qi-Xing Yan, Yun Pan, Hai-Li Huang & Hui Zhao. (2021) Therapeutic Potential of Natural Products in Lung Cancer. International Journal of Pharmacology 17:5, pages 251-261.
Crossref
Ting Jiang, Xisha Chen, Xingcong Ren, Jin-Ming Yang & Yan Cheng. (2021) Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance. Drug Resistance Updates 56, pages 100752.
Crossref
Lorena Carvajal, Jaime Gutiérrez, Eugenia Morselli & Andrea Leiva. (2021) Autophagy Process in Trophoblast Cells Invasion and Differentiation: Similitude and Differences With Cancer Cells. Frontiers in Oncology 11.
Crossref
Xiaoyu Deng, Qinghua Bi, Shihan Chen, Xianhua Chen, Shuhui Li, Zhaoyang Zhong, Wei Guo, Xiaohui Li, Youcai Deng & Yao Yang. (2021) Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 7.
Crossref
Xiao-Lin Su, Jiang-Wei Wang, Hui Che, Chang-Fu WangHai Jiang, Xia Lei, Wan Zhao, Hai-Xue Kuang & Qiu-Hong Wang. (2020) Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer. Chinese Medical Journal 133:24, pages 2987-2997.
Crossref
Hai-Xia Tan, Shao-Liang Yang, Ming-Qing Li & Hai-Yan Wang. (2020) Autophagy suppression of trophoblast cells induces pregnancy loss by activating decidual NK cytotoxicity and inhibiting trophoblast invasion. Cell Communication and Signaling 18:1.
Crossref
Lulu Ni, Zhongjie Li, Xuelin Shi, Chao Yao, Jiangnan Sun, Min Ai, Shuangshuang Li, Yixiao Liu, Fei Xu, Yuetao Zhou, Jiangan Li & Liying Qiu. (2020) Rosthorin A inhibits non-small cell lung cancer cell growth and metastasis through repressing epithelial-mesenchymal transition via downregulating Slug. Anti-Cancer Drugs 31:10, pages 997-1003.
Crossref
Chao Yao, Lin Su, Fei Zhang, Xiaowen Zhu, Yangzhuangzhuang Zhu, Luyao Wei, Xiaoning Jiao, Yifei Hou, Xiao Chen, Wantao Wang, Jie Wang, Xiandan Zhu, Chunpu Zou, Shiguo Zhu & Zihang Xu. (2020) Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis. Cancer Letters 493, pages 167-177.
Crossref
Yang Liu, Wenxiao Jia, Ji Li, Hui Zhu & Jinming Yu. (2020) Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma. Frontiers in Oncology 10.
Crossref
Huan-Zhen Yang & Xi-Han Zhou. (2020) Mechanism for hypoxia inducible factor-1α to promote immune escape and therapeutic tolerance in hepatocellular carcinoma under hypoxic microenvironment. World Chinese Journal of Digestology 28:18, pages 904-913.
Crossref
Jingwen Zhang, Zhihao Zhang, Weiwei Song & Jumin Liu. (2020) EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion. Molecular and Cellular Probes 52, pages 101566.
Crossref
Congwen Li, Guodong Zhu, Zihong Cui, Jihong Zhang, Shengting Zhang & Yunlin Wei. (2020) The strong inhibitory effect of combining anti-cancer drugs AT406 and rocaglamide with blue LED irradiation on colorectal cancer cells. Photodiagnosis and Photodynamic Therapy 30, pages 101797.
Crossref
Peipei Peng, Xiaojin Zhang, Tao Qi, Hao Cheng, Qiuyue Kong, Li Liu, Xiaofei Cao & Zhengnian Ding. (2020) Alpha‐lipoic acid inhibits lung cancer growth via mTOR‐mediated autophagy inhibition. FEBS Open Bio 10:4, pages 607-618.
Crossref
Mi Zhou, Weihua Shao, Haiyun Dai & Xin Zhu. (2020) A Robust Signature Based on Autophagy-Associated LncRNAs for Predicting Prognosis in Lung Adenocarcinoma. BioMed Research International 2020, pages 1-13.
Crossref
Aviad Ben-Shmuel, Guy Biber & Mira Barda-Saad. (2020) Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?. Frontiers in Immunology 11.
Crossref
Li Liu, Lu Yan, Ning Liao, Wan-Qin Wu & Jun-Ling Shi. (2020) A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer. Cancers 12:2, pages 352.
Crossref
Chunle Zhao, Ruizhi He, Ming Shen, Feng Zhu, Min Wang, Yuhui Liu, Hua Chen, Xu Li & Renyi Qin. (2019) PINK1/Parkin-Mediated Mitophagy Regulation by Reactive Oxygen Species Alleviates Rocaglamide A-Induced Apoptosis in Pancreatic Cancer Cells. Frontiers in Pharmacology 10.
Crossref
Steven R. Chamberlin, Aurora Blucher, Guanming Wu, Lynne Shinto, Gabrielle Choonoo, Molly Kulesz-Martin & Shannon McWeeney. (2019) Natural Product Target Network Reveals Potential for Cancer Combination Therapies. Frontiers in Pharmacology 10.
Crossref
Ian C. MacArthur, Yi Bei, Heathcliff Dorado Garcia, Michael V. Ortiz, Joern Toedling, Filippos Klironomos, Jana Rolff, Angelika Eggert, Johannes H. Schulte, Alex Kentsis & Anton G. Henssen. (2019) Prohibitin promotes dedifferentiation and is a potential therapeutic target in neuroblastoma. JCI Insight 4:10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.